SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-16-123222
Filing Date
2016-09-08
Accepted
2016-09-08 16:07:32
Documents
1
Group Members
PONTIFAX (CAYMAN) II L.P.PONTIFAX (ISRAEL) II - INDIVIDUAL INVESTORS L.P.PONTIFAX (ISRAEL) II L.P.PONTIFAX MANAGEMENT 2 G.P. (2007) LTD.PONTIFAX MANAGEMENT II, L.P.RAN NUSSBAUM

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D v448378_sc13d.htm SC 13D 215484
  Complete submission text file 0001144204-16-123222.txt   217157
Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822 (862) 703-7175
Arno Therapeutics, Inc (Subject) CIK: 0001195116 (see all company filings)

IRS No.: 522286452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-83157 | Film No.: 161876248
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARNO THERAPEUTICS, INC. 200 ROUTE 31 NORTH, SUITE 104 FLEMINGTON NJ 08822
Business Address
Kariv Tomer (Filed by) CIK: 0001568077 (see all company filings)

Type: SC 13D